Safety monitoring of precautionary third dose of COVID-19 vaccines in a district in Northern India
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.COVID-19 booster shots are safe, with very few adverse events reported. However, acceptance rates for these crucial precautionary doses remain low compared to initial vaccinations.
Area Of Science
- Immunization and Public Health
- Vaccine Safety Surveillance
- Infectious Disease Epidemiology
Background
- The COVID-19 pandemic, caused by SARS-CoV-2, prompted global vaccination efforts.
- India initiated its vaccination program in January 2021 with Covishield and Covaxin, later introducing booster doses.
Purpose Of The Study
- To assess the safety and adverse events following the administration of COVID-19 precautionary booster doses.
- To evaluate the acceptance rate of COVID-19 booster doses in the Karnal district.
Main Methods
- A descriptive observational study was conducted at COVID-19 vaccination centers in Karnal.
- Adverse drug reactions (ADRs) were collected using a standardized reporting form.
- Causality assessment of reported ADRs was performed using the WHO-UMC scale.
Main Results
- A total of 72,853 individuals received the COVID-19 booster dose.
- Only three ADRs were reported following booster vaccination, all classified as unlikely.
- Booster dose administration numbers were significantly lower than first and second doses.
Conclusions
- COVID-19 booster doses demonstrate a favorable safety profile.
- Low acceptance rates for booster doses were observed, indicating a need for further public health strategies.
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
